FR1729M - New drug, in particular for the treatment of inflammatory and painful manifestations. - Google Patents

New drug, in particular for the treatment of inflammatory and painful manifestations.

Info

Publication number
FR1729M
FR1729M FR885108A FR885108A FR1729M FR 1729 M FR1729 M FR 1729M FR 885108 A FR885108 A FR 885108A FR 885108 A FR885108 A FR 885108A FR 1729 M FR1729 M FR 1729M
Authority
FR
France
Prior art keywords
inflammatory
treatment
new drug
painful manifestations
manifestations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR885108A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR885108A priority Critical patent/FR1729M/en
Application granted granted Critical
Publication of FR1729M publication Critical patent/FR1729M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR885108A 1961-10-17 1962-01-17 New drug, in particular for the treatment of inflammatory and painful manifestations. Active FR1729M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR885108A FR1729M (en) 1961-10-17 1962-01-17 New drug, in particular for the treatment of inflammatory and painful manifestations.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR876199A FR1369967A (en) 1961-10-17 1961-10-17 New quinoline derivatives and method of preparation
FR885108A FR1729M (en) 1961-10-17 1962-01-17 New drug, in particular for the treatment of inflammatory and painful manifestations.

Publications (1)

Publication Number Publication Date
FR1729M true FR1729M (en) 1963-03-11

Family

ID=8764834

Family Applications (3)

Application Number Title Priority Date Filing Date
FR876199A Expired FR1369967A (en) 1961-07-10 1961-10-17 New quinoline derivatives and method of preparation
FR884601A Active FR2574M (en) 1961-10-17 1962-01-11 New drug, in particular for the treatment of pain and inflammatory symptoms.
FR885108A Active FR1729M (en) 1961-10-17 1962-01-17 New drug, in particular for the treatment of inflammatory and painful manifestations.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR876199A Expired FR1369967A (en) 1961-07-10 1961-10-17 New quinoline derivatives and method of preparation
FR884601A Active FR2574M (en) 1961-10-17 1962-01-11 New drug, in particular for the treatment of pain and inflammatory symptoms.

Country Status (1)

Country Link
FR (3) FR1369967A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2193583B1 (en) * 1972-07-28 1976-03-05 Synthelabo

Also Published As

Publication number Publication date
FR2574M (en) 1964-06-08
FR1369967A (en) 1964-08-21

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
BE628497A (en) New compound which can be used in particular for the treatment of inflammatory and / or painful manifestations
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR28F (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR3875M (en) New drug particularly suitable for the treatment of tuberculosis infections.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR1783M (en) Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.